MEFNX
Price
$9.23
Change
+$0.23 (+2.56%)
Updated
Apr 24 closing price
Net Assets
3.85B
PMBPX
Price
$42.75
Change
+$0.61 (+1.45%)
Updated
Apr 24 closing price
Net Assets
28.88B
Ad is loading...

MEFNX vs PMBPX

Header iconMEFNX vs PMBPX Comparison
Open Charts MEFNX vs PMBPXBanner chart's image
MassMutual Mid Cap Growth R3
Price$9.23
Change+$0.23 (+2.56%)
VolumeN/A
Net Assets3.85B
Principal MidCap R5
Price$42.75
Change+$0.61 (+1.45%)
VolumeN/A
Net Assets28.88B
MEFNX vs PMBPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MEFNX vs. PMBPX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEFNX is a StrongBuy and PMBPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMBPX has more cash in the bank: 28.9B vs. MEFNX (3.85B). MEFNX pays higher dividends than PMBPX: MEFNX (0.42) vs PMBPX (0.01). MEFNX was incepted earlier than PMBPX: MEFNX (22 years) vs PMBPX (24 years). MEFNX (1.37) is less costly to investors than PMBPX (0.84). MEFNX is a more actively managed with annual turnover of: 32.00 vs. PMBPX (10.50). MEFNX (0) and PMBPX (0) have matching initial minimum investment requirements. PMBPX annual gain was more profitable for investors over the last year : 6.75 vs. MEFNX (-24.78). PMBPX return over 5 years is better than : 68.04 vs. MEFNX (-41.03).
MEFNXPMBPXMEFNX / PMBPX
Total Expense Ratio1.360.84162%
Annual Report Gross Expense Ratio1.370.84163%
Fund Existence22 years24 years-
Gain YTD-12.023-3.037396%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets3.85B28.9B13%
Annual Yield % from dividends0.420.015,226%
Returns for 1 year-24.786.75-367%
Returns for 3 years-38.3821.73-177%
Returns for 5 years-41.0368.04-60%
Returns for 10 years-47.0182.65-57%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FMXKX6.81N/A
N/A
Federated Hermes Max-Cap Index R
CBALX48.68N/A
N/A
Columbia Balanced Inst
DLRHX22.26N/A
N/A
Macquarie Healthcare R
CESGX11.13N/A
N/A
Coho Relative Value ESG
FEIRX32.90N/A
N/A
Fidelity Advisor Equity Income M